Bolt Biotherapeutics Inc
BOLT
$5.53-0.12 (-2.12%)
Aug 2, 2025, 4:00 PM
Financials
| 52Week High | 15.60 | 52Week Low | 5.20 |
| Beta | 0.89 | Current Ratio Annual | 3.20 |
| Current Ratio Quarterly | 3.13 | Market Cap | 10.60M |
| Net Profit Margin TTM | -1,303.22 | Operating Margin TTM | -1,405.53 |
| Price To Book | 0.23 | Price To Sales TTM | 2.91 |
| Quick Ratio Annual | 3.11 | Quick Ratio Quarterly | 2.92 |
| Return On Assets TTM | -60.47 | Return On Equity TTM | -96.75 |
| Return On Investment TTM | -96.75 | Revenue Growth3Y | 82.75 |
| Revenue Growth5Y | 103.56 | Revenue Growth Quarterly Yoy | -76.83 |
| Revenue Growth TTMYoy | -67.87 | Revenue Per Share TTM | 1.90 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 30 | 2 | 10 | 8 | 5 | 14 | 18.33M | $7.32M |
| Jun 30, 2025 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | $0 |
| Change | 30(100%) | 2(100%) | 9(90%) | 8(100%) | 5(100%) | 14(100%) | 18.33M(100%) | $7.32M(100%) |